IE
ZEPP

Israel Englander’s Zepp Health ZEPP Stock Holding History

Israel Englander’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-342,504
Closed -$4.09M – 6479
2026
Q1 		$4.09M Sell
342,504
-24,322
-7% -$498K ﹤0.01% 3174
2025
Q4 		$9.88M Buy
366,826
+120,750
+49% +$4.31M ﹤0.01% 2281
2025
Q3 		$11.3M Buy
+246,076
New +$7.45M ﹤0.01% 2282
2024
Q1 		– Sell
-7,910
Closed -$44.9K – 6733
2023
Q4 		$44.9K Buy
7,910
+3,049
+63% +$15.3K ﹤0.01% 5498
2023
Q3 		$22.4K Buy
4,861
+612
+14% +$2.89K ﹤0.01% 5625
2023
Q2 		$19.4K Sell
4,249
-1,664
-28% -$8.39K ﹤0.01% 5638
2023
Q1 		$31K Sell
5,913
-2,446
-29% -$17.3K ﹤0.01% 5762
2022
Q4 		$48K Sell
8,359
-6,179
-43% -$33.1K ﹤0.01% 5788
2022
Q3 		$80K Sell
14,538
-6,498
-31% -$47K ﹤0.01% 6038
2022
Q2 		$156K Sell
21,036
-8,968
-30% -$82.6K ﹤0.01% 5757
2022
Q1 		$346K Sell
30,004
-22,445
-43% -$363K ﹤0.01% 5429
2021
Q4 		$1.06M Buy
52,449
+47,686
+1,001% +$1.43M ﹤0.01% 4358
2021
Q3 		$153K Buy
4,763
+424
+10% +$17.5K ﹤0.01% 6241
2021
Q2 		$204K Sell
4,339
-33,112
-88% -$1.38M ﹤0.01% 6006
2021
Q1 		$1.61M Buy
+37,451
New +$2.18M ﹤0.01% 3739
2020
Q4 		– Sell
-34,661
Closed -$1.78K – 5648
2020
Q3 		$1.78K Sell
34,661
-80,678
-70% -$4.43M ﹤0.01% 2681
2020
Q2 		$5.7M Buy
115,339
+58,930
+104% +$2.72M 0.01% 1639
2020
Q1 		$2.96M Sell
56,409
-16,502
-23% -$893K 0.01% 1740
2019
Q4 		$3.51M Buy
72,911
+56,758
+351% +$2.38M ﹤0.01% 2207
2019
Q3 		$646K Sell
16,153
-11,412
-41% -$479K ﹤0.01% 3101
2019
Q2 		$1.1M Buy
27,565
+16,314
+145% +$681K ﹤0.01% 2745
2019
Q1 		$589K Buy
11,251
+7,809
+227% +$421K ﹤0.01% 3166
2018
Q4 		$135K Sell
3,442
-10,133
-75% -$398K ﹤0.01% 3502
2018
Q3 		$581K Buy
13,575
+4,446
+49% +$179K ﹤0.01% 3159
2018
Q2 		$360K Sell
9,129
-22,800
-71% -$938K ﹤0.01% 3313
2018
Q1 		$1.36M Buy
+31,929
New +$1.42M ﹤0.01% 2542

Other funds holding ZEPP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's ZEPP Position: Q2 2026 in Review

Israel Englander sold out of Zepp Health (ZEPP) in Q2 2026, closing a stake of 342,504 shares — an estimated $4.09M sold.

Israel Englander first reported a position in ZEPP in Q1 2018 and held it in 26 quarters. The position peaked at $11.3M in Q3 2025. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • Israel Englander reported no remaining Zepp Health position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 342,504 Zepp Health shares in Q2 2026, an estimated $4.09M.
  • Israel Englander first reported a position in Zepp Health in Q1 2018 and held it in 26 quarters.
  • Israel Englander's Zepp Health position peaked at $11.3M in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.